Literature DB >> 26538580

Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study.

Bruce M Psaty1, Joseph A Delaney2, Alice M Arnold2, Lesley H Curtis2, Annette L Fitzpatrick2, Susan R Heckbert2, Barbara McKnight2, Diane Ives2, John S Gottdiener2, Lewis H Kuller2, W T Longstreth2.   

Abstract

BACKGROUND: Increasingly, the diagnostic codes from administrative claims data are being used as clinical outcomes. METHODS AND
RESULTS: Data from the Cardiovascular Health Study (CHS) were used to compare event rates and risk factor associations between adjudicated hospitalized cardiovascular events and claims-based methods of defining events. The outcomes of myocardial infarction (MI), stroke, and heart failure were defined in 3 ways: the CHS adjudicated event (CHS[adj]), selected International Classification of Diseases, Ninth Edition diagnostic codes only in the primary position for Medicare claims data from the Center for Medicare & Medicaid Services (CMS[1st]), and the same selected diagnostic codes in any position (CMS[any]). Conventional claims-based methods of defining events had high positive predictive values but low sensitivities. For instance, the positive predictive value of International Classification of Diseases, Ninth Edition code 410.x1 for a new acute MI in the first position was 90.6%, but this code identified only 53.8% of incident MIs. The observed event rates for CMS[1st] were low. For MI, the incidence was 14.9 events per 1000 person-years for CHS[adj] MI, 8.6 for CMS[1st] MI, and 12.2 for CMS[any] MI. In general, cardiovascular disease risk factor associations were similar across the 3 methods of defining events. Indeed, traditional cardiovascular disease risk factors were also associated with all first hospitalizations not resulting from an MI.
CONCLUSIONS: The use of diagnostic codes from claims data as clinical events, especially when restricted to primary diagnoses, leads to an underestimation of event rates. Additionally, claims-based events data represent a composite end point that includes the outcome of interest and selected (misclassified) nonevent hospitalizations.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  epidemiology; heart failure; incidence; myocardial infarction; stroke

Mesh:

Substances:

Year:  2015        PMID: 26538580      PMCID: PMC4814341          DOI: 10.1161/CIRCULATIONAHA.115.018610

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  43 in total

1.  Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.

Authors:  Paul Muntner; Lisandro D Colantonio; Mary Cushman; David C Goff; George Howard; Virginia J Howard; Brett Kissela; Emily B Levitan; Donald M Lloyd-Jones; Monika M Safford
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

2.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

3.  Medicare at 50--origins and evolution.

Authors:  David Blumenthal; Karen Davis; Stuart Guterman
Journal:  N Engl J Med       Date:  2015-01-14       Impact factor: 91.245

4.  Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

Authors:  Marc A Pfeffer; Brian Claggett; Susan F Assmann; Robin Boineau; Inder S Anand; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; John F Heitner; Eldrin F Lewis; Eileen O'Meara; Jean-Lucien Rouleau; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Sonja M McKinlay; Bertram Pitt
Journal:  Circulation       Date:  2014-11-18       Impact factor: 29.690

5.  Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.

Authors:  David J Graham; Marsha E Reichman; Michael Wernecke; Rongmei Zhang; Mary Ross Southworth; Mark Levenson; Ting-Chang Sheu; Katrina Mott; Margie R Goulding; Monika Houstoun; Thomas E MaCurdy; Chris Worrall; Jeffrey A Kelman
Journal:  Circulation       Date:  2014-10-30       Impact factor: 29.690

6.  Increasing trend in admissions for malignant hypertension and hypertensive encephalopathy in the United States.

Authors:  Linnea A Polgreen; Manish Suneja; Fan Tang; Barry L Carter; Philip M Polgreen
Journal:  Hypertension       Date:  2015-03-23       Impact factor: 10.190

7.  Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease.

Authors:  Vicente F Corrales-Medina; Karina N Alvarez; Lisa A Weissfeld; Derek C Angus; Julio A Chirinos; Chung-Chou H Chang; Anne Newman; Laura Loehr; Aaron R Folsom; Mitchell S Elkind; Mary F Lyles; Richard A Kronmal; Sachin Yende
Journal:  JAMA       Date:  2015-01-20       Impact factor: 56.272

8.  Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study.

Authors:  Nancy R Cook; Paul M Ridker
Journal:  JAMA Intern Med       Date:  2014-12       Impact factor: 21.873

9.  Validity of hospital discharge diagnosis codes for stroke: the Atherosclerosis Risk in Communities Study.

Authors:  Sydney A Jones; Rebecca F Gottesman; Eyal Shahar; Lisa Wruck; Wayne D Rosamond
Journal:  Stroke       Date:  2014-09-04       Impact factor: 7.914

10.  Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockers.

Authors:  David J Graham; Esther H Zhou; Stephen McKean; Mark Levenson; Katlyn Calia; Kate Gelperin; Xiao Ding; Thomas E MaCurdy; Chris Worrall; Jeffrey A Kelman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-11-26       Impact factor: 2.890

View more
  58 in total

1.  Trajectories of Nonagenarian Health: Sex, Age, and Period Effects.

Authors:  Michelle C Odden; William Jen Hoe Koh; Alice M Arnold; Andreea M Rawlings; Bruce M Psaty; Anne B Newman
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

2.  Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities study.

Authors:  Montika Bush; Til Stürmer; Sally C Stearns; Ross J Simpson; M Alan Brookhart; Wayne Rosamond; Anna M Kucharska-Newton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-06       Impact factor: 2.890

3.  The Application of Genomics in Diabetes: Barriers to Discovery and Implementation.

Authors:  James S Floyd; Bruce M Psaty
Journal:  Diabetes Care       Date:  2016-11       Impact factor: 19.112

4.  Demonstrating the Value of Outcomes in Echocardiography: Imaging-Based Registries in Improving Patient Care.

Authors:  Jordan B Strom; Varsha K Tanguturi; Sherif F Nagueh; Allan L Klein; Warren J Manning
Journal:  J Am Soc Echocardiogr       Date:  2019-09-25       Impact factor: 5.251

5.  Abdominal aortic calcification (AAC) and ankle-brachial index (ABI) predict health care costs and utilization in older men, independent of prevalent clinical cardiovascular disease and each other.

Authors:  John T Schousboe; Tien N Vo; Lisa Langsetmo; Selcuk Adabag; Pawel Szulc; Joshua R Lewis; Allyson M Kats; Brent C Taylor; Kristine E Ensrud
Journal:  Atherosclerosis       Date:  2020-01-19       Impact factor: 5.162

6.  Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND Study.

Authors:  Jordan B Strom; Yuansong Zhao; Kamil F Faridi; Hector Tamez; Neel M Butala; Linda R Valsdottir; Jeptha Curtis; J Matthew Brennan; Changyu Shen; Mike Boulware; Jeffrey J Popma; Robert W Yeh
Journal:  Circ Cardiovasc Interv       Date:  2019-11-07       Impact factor: 6.546

7.  Patterns of Cardiovascular Risk Factors in Old Age and Survival and Health Status at 90.

Authors:  Michelle C Odden; Andreea M Rawlings; Alice M Arnold; Mary Cushman; Mary L Biggs; Bruce M Psaty; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-10-15       Impact factor: 6.053

8.  Relation of coagulation factor XI with incident coronary heart disease and stroke: the Cardiovascular Health Study.

Authors:  Duke Appiah; Oluwaseun E Fashanu; Susa R Heckbert; Mary Cushman; Bruce M Psaty; Aaron R Folsom
Journal:  Blood Coagul Fibrinolysis       Date:  2017-07       Impact factor: 1.276

9.  Targeting the Correct Population When Designing Transitional Care Programs for Medicare Patients Hospitalized With Heart Failure.

Authors:  Faraz S Ahmad; Ramsey M Wehbe; Preeti Kansal; Hannah A Jackson; Allen S Anderson; Clyde W Yancy; R Kannan Mutharasan
Journal:  JAMA Cardiol       Date:  2017-11-01       Impact factor: 14.676

10.  Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.

Authors:  Samia Mora; Nanette K Wenger; Nancy R Cook; Jingmin Liu; Barbara V Howard; Marian C Limacher; Simin Liu; Karen L Margolis; Lisa W Martin; Nina P Paynter; Paul M Ridker; Jennifer G Robinson; Jacques E Rossouw; Monika M Safford; JoAnn E Manson
Journal:  JAMA Intern Med       Date:  2018-09-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.